216 related articles for article (PubMed ID: 4989245)
1. [Different response of superficial and deep lymph nodes to drug therapy in malignant lymphoreticulopathy].
Morgenfeld MC; Helft F; Bomchil G
Therapeutique; 1969 Mar; 45(3):294-300. PubMed ID: 4989245
[No Abstract] [Full Text] [Related]
2. [Different response of the superficial and deep lymph nodes to therapy in malignant lymphoreticulopathies].
Morgenfeld MC; Helft F; Bomchil G
Sem Hop; 1968 Apr; 44(18):1247-53. PubMed ID: 4299429
[No Abstract] [Full Text] [Related]
3. [Differing sensitivity to cytostatic drugs in superficial and deep groups of lymph nodes].
Aggio MC; Alvarez RV; Rocca EO; Bouzat J
Sangre (Barc); 1970; 15(3):379-82. PubMed ID: 5486765
[No Abstract] [Full Text] [Related]
4. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
5. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
6. [Ambulatory endoxan therapy by high doses].
Fischer M; Martin H; Schubert JC
Dtsch Med Wochenschr; 1967 Jun; 92(25):1145-50. PubMed ID: 5338225
[No Abstract] [Full Text] [Related]
7. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
8. Recent advances in chemotherapy of lymphoma.
Lenhard RE; Owens AH
Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
[No Abstract] [Full Text] [Related]
9. [Cytological examination of the lymph nodes in lympho-proliferative diseases].
VISCA U; FORNI A
Recenti Prog Med; 1962 Dec; 33():507-68. PubMed ID: 13997474
[No Abstract] [Full Text] [Related]
10. [Methylhydrazine in the therapy of malignant lymphopathies].
Beltrametti L; Almici C
Policlinico Prat; 1967 Jan; 74(3):82-5. PubMed ID: 4878309
[No Abstract] [Full Text] [Related]
11. [Secondary tumors in hemoblastoses during cytostatic treatment].
Hartwich G; Butzler W
Med Klin; 1971 Oct; 66(43):1445-50. PubMed ID: 5001553
[No Abstract] [Full Text] [Related]
12. [High-dosed cyclophosphamide therapy of malignant diseases of the lymphoreticulum].
Kühböck J; Pietschmann H
Wien Klin Wochenschr; 1965 Nov; 77(44):883-6. PubMed ID: 5328863
[No Abstract] [Full Text] [Related]
13. [Use of milurit in hyperuricemia in patients with malignant hemopathies].
Poddubnaia IV; Mansurov AN; Fominykh VG
Klin Med (Mosk); 1975 Mar; 53(3):94-9. PubMed ID: 1090781
[No Abstract] [Full Text] [Related]
14. Lymphocytic beta-glucuronidase in the lymphoproliferative syndromes.
Zittoun R; Cadiou M; Dao C; Blanc JM; Bousser J
Biomedicine; 1973 Sep; 18(5):515-20. PubMed ID: 4201753
[No Abstract] [Full Text] [Related]
15. [The role of vinblastine in the treatment of malignant lymphomas].
Eridani S; Esposito R; Ponti GB; Giangrande A
Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
[No Abstract] [Full Text] [Related]
16. Haemolytic anaemia in malignant lymphoreticuloendothelial diseases.
Stojcevski T
Haematologia (Budap); 1974; 8(1-4):507-16. PubMed ID: 4618234
[No Abstract] [Full Text] [Related]
17. Leukemia and lymphoma.
White LP
Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
[No Abstract] [Full Text] [Related]
18. [Experiences with intense cytostatic therapy of malignant tumors].
Siering H; Reinhardt M
Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374
[No Abstract] [Full Text] [Related]
19. [Ixoten therapy in malignant lymphomas].
Pötzi P; Aiginger P; Kühböck J
Acta Med Austriaca; 1979; 6(5):247-9. PubMed ID: 400215
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of reticulosarcomas and lymphosarcomas. A 10-year analysis].
Chauvergne J; Hoerni-Simon G; Durand M; Meuge C; Goerni B
Bull Cancer; 1974; 61(1):119-28. PubMed ID: 4142404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
